MGRM vs. CLPT, OM, NNOX, NYXH, SMTI, ZIMV, STIM, TCMD, SNWV, and NVRO
Should you be buying Monogram Orthopaedics stock or one of its competitors? The main competitors of Monogram Orthopaedics include ClearPoint Neuro (CLPT), Outset Medical (OM), Nano-X Imaging (NNOX), Nyxoah (NYXH), Sanara MedTech (SMTI), ZimVie (ZIMV), Neuronetics (STIM), Tactile Systems Technology (TCMD), SANUWAVE Health (SNWV), and Nevro (NVRO). These companies are all part of the "medical equipment" industry.
Monogram Orthopaedics vs. Its Competitors
ClearPoint Neuro (NASDAQ:CLPT) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk, community ranking and earnings.
ClearPoint Neuro received 22 more outperform votes than Monogram Orthopaedics when rated by MarketBeat users. Likewise, 86.21% of users gave ClearPoint Neuro an outperform vote while only 60.00% of users gave Monogram Orthopaedics an outperform vote.
Monogram Orthopaedics has lower revenue, but higher earnings than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Monogram Orthopaedics, indicating that it is currently the more affordable of the two stocks.
In the previous week, ClearPoint Neuro had 3 more articles in the media than Monogram Orthopaedics. MarketBeat recorded 5 mentions for ClearPoint Neuro and 2 mentions for Monogram Orthopaedics. Monogram Orthopaedics' average media sentiment score of 1.60 beat ClearPoint Neuro's score of 1.19 indicating that Monogram Orthopaedics is being referred to more favorably in the news media.
30.1% of ClearPoint Neuro shares are held by institutional investors. Comparatively, 0.4% of Monogram Orthopaedics shares are held by institutional investors. 7.0% of ClearPoint Neuro shares are held by insiders. Comparatively, 28.1% of Monogram Orthopaedics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
ClearPoint Neuro has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, Monogram Orthopaedics has a beta of 0.42, indicating that its share price is 58% less volatile than the S&P 500.
ClearPoint Neuro presently has a consensus target price of $25.00, indicating a potential upside of 106.95%. Monogram Orthopaedics has a consensus target price of $5.40, indicating a potential upside of 105.32%. Given ClearPoint Neuro's higher possible upside, equities research analysts clearly believe ClearPoint Neuro is more favorable than Monogram Orthopaedics.
Monogram Orthopaedics has a net margin of 0.00% compared to ClearPoint Neuro's net margin of -59.64%. ClearPoint Neuro's return on equity of -62.10% beat Monogram Orthopaedics' return on equity.
Summary
ClearPoint Neuro beats Monogram Orthopaedics on 10 of the 19 factors compared between the two stocks.
Get Monogram Orthopaedics News Delivered to You Automatically
Sign up to receive the latest news and ratings for MGRM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MGRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Monogram Orthopaedics Competitors List
Related Companies and Tools
This page (NASDAQ:MGRM) was last updated on 6/12/2025 by MarketBeat.com Staff
Buy MGRM Stock Free MGRM Stock Alerts